Cargando…
METHYLPREDNISOLONE VERSUS DEXAMETHASONE FOR TREATMENT OF SEVERE OR CRITICAL COVID-19: A QUASI-EXPERIMENTAL STUDY (MD TREAT)
INTRO: Dexamethasone, a corticosteroid, was recently demonstrated to be the only medication capable of reducing mortality in severe COVID disease in the UK's Recovery Trial. There is a need to compare different steroids because it is well recognised that different corticosteroids have varied ph...
Autores principales: | Nasir, N., Fatima, S., Awan, S., Zakariya, M., Arshad, A., Khalid, F., Aqeel, M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier Ltd.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10186939/ http://dx.doi.org/10.1016/j.ijid.2023.04.374 |
Ejemplares similares
-
Comparison of efficacy of dexamethasone and methylprednisolone in moderate to severe covid 19 disease
por: Fatima, Syeda Arzinda, et al.
Publicado: (2020) -
Methylprednisolone versus Dexamethasone for Control of Vertigo in Patients with Definite Meniere's disease
por: Masoumi, Elham, et al.
Publicado: (2017) -
Dexamethasone/hydrocortisone/methylprednisolone: Disseminated cryptococcosis following off label use of dexamethasone, hydrocortisone and methylprednisolone: case report
Publicado: (2022) -
Pulse dexamethasone therapy versus pulse methylprednisolone therapy for treatment of Graves's ophthalmopathy
por: Philip, Rajeev, et al.
Publicado: (2013) -
Pulse Methylprednisolone Versus Dexamethasone in COVID-19: A Multicenter Cohort Study
por: Watanabe, Atsuyuki, et al.
Publicado: (2023)